Aarron Willingham

8.7k total citations · 3 hit papers
23 papers, 2.3k citations indexed

About

Aarron Willingham is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Aarron Willingham has authored 23 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Immunology. Recurrent topics in Aarron Willingham's work include RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Aarron Willingham is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Aarron Willingham collaborates with scholars based in United States, Switzerland and Germany. Aarron Willingham's co-authors include T Gingeras, Philipp Kapranov, Charles S. Zuker, Richard G. Walker, Pedro Aza‐Blanc, Serge Batalov, Anthony P. Orth, Bo Wen, Peter G. Schultz and Esther C. Peters and has published in prestigious journals such as Science, Cell and Journal of the American Chemical Society.

In The Last Decade

Aarron Willingham

23 papers receiving 2.2k citations

Hit Papers

A Strategy for Probing the Function of Noncoding RNAs Fin... 2000 2026 2008 2017 2005 2007 2000 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aarron Willingham United States 14 1.7k 924 292 215 195 23 2.3k
Yvonne J. K. Edwards United States 26 1.7k 1.0× 206 0.2× 105 0.4× 174 0.8× 566 2.9× 67 2.5k
Florian Heyd Germany 23 1.2k 0.7× 252 0.3× 78 0.3× 55 0.3× 196 1.0× 64 1.8k
Peter Stoilov United States 29 2.9k 1.7× 578 0.6× 372 1.3× 22 0.1× 304 1.6× 51 3.5k
Yongsheng Shi United States 28 3.2k 1.9× 440 0.5× 210 0.7× 36 0.2× 130 0.7× 65 3.6k
Sheikh Riazuddin United States 26 2.0k 1.2× 125 0.1× 208 0.7× 195 0.9× 504 2.6× 98 2.5k
Teresa Gilbert United States 12 1.2k 0.7× 184 0.2× 866 3.0× 70 0.3× 132 0.7× 14 2.3k
Jenn‐Yah Yu Taiwan 16 1.7k 1.0× 717 0.8× 177 0.6× 24 0.1× 336 1.7× 26 2.1k
Jason R. Willer United States 19 1.2k 0.7× 170 0.2× 97 0.3× 102 0.5× 507 2.6× 31 1.8k
José Sotelo‐Silveira Uruguay 22 944 0.6× 189 0.2× 303 1.0× 25 0.1× 125 0.6× 80 1.5k
Suzanne Rademakers Netherlands 19 1.7k 1.0× 307 0.3× 162 0.6× 28 0.1× 408 2.1× 23 2.3k

Countries citing papers authored by Aarron Willingham

Since Specialization
Citations

This map shows the geographic impact of Aarron Willingham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aarron Willingham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aarron Willingham more than expected).

Fields of papers citing papers by Aarron Willingham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aarron Willingham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aarron Willingham. The network helps show where Aarron Willingham may publish in the future.

Co-authorship network of co-authors of Aarron Willingham

This figure shows the co-authorship network connecting the top 25 collaborators of Aarron Willingham. A scholar is included among the top collaborators of Aarron Willingham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aarron Willingham. Aarron Willingham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chernyak, Natalia, Saraswathi Naravula, Ying Chen, et al.. (2024). Discovery and Evaluation of TLR-Targeted Immune Agonists. Journal of Medicinal Chemistry. 67(18). 16222–16234. 2 indexed citations
2.
Chen, Ying, Natalia Chernyak, Fan Zhang, et al.. (2023). Development and application of an in vitro assay to assess target-independent B-cell activation by targeted TLR7 immune agonists. Journal of Immunological Methods. 522. 113553–113553. 2 indexed citations
3.
Malefyt, René de Waal, et al.. (2023). Investigating combination benefit of PD1 and LAG3 co-blockade using an engineered cellular bioassay. International Immunopharmacology. 119. 109566–109566. 1 indexed citations
4.
Hsu, Yen‐Pang, et al.. (2023). Site-Specific Antibody Conjugation Using Modified Bisected N-Glycans: Method Development and Potential toward Tunable Effector Function. Bioconjugate Chemistry. 34(9). 1633–1644. 8 indexed citations
5.
Selman, Mohammed, Weilong Zhao, Jiwon Jung, et al.. (2023). Engineering Oncolytic Coxsackievirus A21 with Small Transgenes and Enabling Cell-Mediated Virus Delivery by Integrating Viral cDNA into the Genome. Journal of Virology. 97(5). e0030923–e0030923. 9 indexed citations
6.
Vessillier, Sandrine, Madeline Fort, Heather Hinton, et al.. (2020). Development of the first reference antibody panel for qualification and validation of cytokine release assay platforms – Report of an international collaborative study. SHILAP Revista de lepidopterología. 2(4). 100042–100042. 9 indexed citations
7.
Willingham, Aarron, et al.. (2019). Evaluation of a TGN1412 analogue using in vitro assays and two immune humanized mouse models. Toxicology and Applied Pharmacology. 372. 57–69. 13 indexed citations
8.
Cherwinski, Holly, Manjiri Sathe, Wolfgang Seghezzi, et al.. (2018). Establishment of engineered cell-based assays mediating LAG3 and PD1 immune suppression enables potency measurement of blocking antibodies and assessment of signal transduction. Journal of Immunological Methods. 456. 7–14. 38 indexed citations
9.
Fucini, Raymond V., et al.. (2012). Adenosine Modification May Be Preferred for Reducing siRNA Immune Stimulation. Nucleic Acid Therapeutics. 22(3). 205–210. 20 indexed citations
10.
Zhao, Lihong, et al.. (2012). Single-stranded microRNA mimics. RNA. 18(10). 1796–1804. 40 indexed citations
11.
Kenski, Denise M., Gabor Butora, Aarron Willingham, et al.. (2012). siRNA-optimized Modifications for Enhanced In Vivo Activity. Molecular Therapy — Nucleic Acids. 1. e5–e5. 65 indexed citations
12.
Haringsma, Henry J., Jing Li, Ferdie Soriano, et al.. (2012). mRNA knockdown by single strand RNA is improved by chemical modifications. Nucleic Acids Research. 40(9). 4125–4136. 33 indexed citations
13.
Kenski, Denise M., Aarron Willingham, Henry J. Haringsma, Jing Li, & W. Michael Flanagan. (2012). In Vivo Activity and Duration of Short Interfering RNAs Containing a Synthetic 5′-Phosphate. Nucleic Acid Therapeutics. 22(2). 90–95. 8 indexed citations
14.
Kenski, Denise M., Jing Li, Aarron Willingham, et al.. (2009). Analysis of acyclic nucleoside modifications in siRNAs finds sensitivity at position 1 that is restored by 5′-terminal phosphorylation both in vitro and in vivo. Nucleic Acids Research. 38(2). 660–671. 67 indexed citations
15.
Kapranov, Philipp, Aarron Willingham, & T Gingeras. (2007). Genome-wide transcription and the implications for genomic organization. Nature Reviews Genetics. 8(6). 413–423. 547 indexed citations breakdown →
16.
Willingham, Aarron & T Gingeras. (2006). TUF Love for “Junk” DNA. Cell. 125(7). 1215–1220. 120 indexed citations
17.
Willingham, Aarron, Sujit Dike, Jill Cheng, et al.. (2006). Transcriptional Landscape of the Human and Fly Genomes: Nonlinear and Multifunctional Modular Model of Transcriptomes. Cold Spring Harbor Symposia on Quantitative Biology. 71(0). 101–110. 15 indexed citations
18.
Willingham, Aarron, Anthony P. Orth, Serge Batalov, et al.. (2005). A Strategy for Probing the Function of Noncoding RNAs Finds a Repressor of NFAT. Science. 309(5740). 1570–1573. 597 indexed citations breakdown →
19.
Willingham, Aarron, Quinn L. Deveraux, Garret M. Hampton, & Pedro Aza‐Blanc. (2004). RNAi and HTS: exploring cancer by systematic loss-of-function. Oncogene. 23(51). 8392–8400. 48 indexed citations
20.
Willingham, Aarron & Thomas A. Keil. (2004). A tissue specific cytochrome P450 required for the structure and function of Drosophila sensory organs. Mechanisms of Development. 121(10). 1289–1297. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026